ReviewFrontiers in endocrinology2026
Challenges and dilemmas of exercise therapy in the management of osteoporosis: a narrative review.
Review in Frontiers in endocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Osteoporosis is a chronic, progressive bone condition that impacts over 200 million people globally, with fragility fractures significantly burdening healthcare systems and diminishing patient quality of life. Exercise is universally recommended as a foundational non-pharmacological intervention for osteoporosis management; however, a persistent translational gap separates the efficacy demonstrated in controlled trials from the outcomes observed in real-world clinical practice. This narrative review identifies and critically examines the multifaceted challenges confronting the evidence-based application of exercise therapy in contemporary osteoporosis care. Seven principal interrelated dilemmas are elucidated: the surrogate endpoint dependency on bone mineral density (BMD) rather than fracture incidence, profound heterogeneity of osteogenic effects across exercise modalities, the tension between effective osteogenic thresholds (≥70% 1RM) and safety concerns in high-risk subgroups, the absence of validated patient stratification tools, poor real-world adherence amid scarce supervised infrastructure and fragmented care pathways, pervasive nutritional inadequacies that undermine the skeletal response to mechanical loading, and methodologically heterogeneous evidence for traditional mind-body exercises that limits their equivalence to progressive resistance training. The reversibility of bone gains upon detraining further underscores that exercise must be conceptualized as a lifelong behavior rather than a time-limited intervention. Future priorities include fracture-powered pragmatic trials, validated osteoporosis-specific pre-exercise risk stratification instruments, implementation science addressing behavioral and systemic barriers, and integrated multidisciplinary care models that unite exercise professionals with bone specialists and dietitians. Until such evidence matures, clinicians must navigate a landscape of conditional recommendations, individualized risk-benefit assessments, and honest communication of uncertainty to patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.